• A
  • |
  • A
  • Text size

AMA News Room

May 7, 2013

AMA to Hold Webinar on Risk-Benefit Assessment for Opioid Prescribing

For immediate release:
May 7, 2013

CHICAGO – The American Medical Association (AMA) will host a free webinar to help physicians better understand the importance of risk-benefit assessments when prescribing opioids to patients with chronic pain. This webinar is part of a series of AMA webinars on topics related to responsible opioid prescribing. It will be held on May 15 at 1:00 p.m. EDT and will be archived online for on-demand viewing after May 15.

“Prescription drug abuse is a serious epidemic that cannot be ignored, and any action we take to curb it must ensure that patients who are suffering from chronic pain get the treatment they need,” said AMA President Jeremy A. Lazarus, M.D. “The AMA is pleased to offer a series of webinars to help physicians combat prescription drug abuse while promoting responsible pain management.”

While overuse and misuse of prescription drugs is a serious problem, a great deal of human pain and suffering remains inadequately treated. According to a 2011 Institute of Medicine report, 100 million Americans suffer from chronic pain. Many of these chronic pain sufferers need prescription opioids to function in their day-to-day lives.

Long-term opioid therapy for chronic pain may be appropriate and beneficial for some patients, but it may be harmful for others. Risk-benefit assessments conducted before a patient is prescribed opioids can minimize the potential for misuse.

During the webinar, Daniel P. Alford, MD, will provide an overview of the:

  • evidence for the use of opioids for chronic pain;
  • appropriate assessment, monitoring and documentation strategies; and
  • practical framework for decision-making on the initiation, maintenance and discontinuation of opioids for the treatment of chronic pain.

The program is being offered free thanks to support of the Prescribers’ Clinical Support System for Opioid Therapies, a collaborative of provider organizations that received grant funding from the Substance Abuse and Mental Health Services Administration. To register for the webinar, visit http://eo2.commpartners.com/users/ama/session.php?id=10666.

#   #   #

Media Contact:
Shannon (O’Brien) Breymaier
AMA Media Relations
(312) 464-4443

 

Follow AMA on and .